This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Goldman Scarlato & Karon, P.C. Announces Investigation Of STEC, Inc.

Goldman Scarlato & Karon, P.C. (“GSK”) commenced an investigation into the August 5, 2009 secondary offering of shares by STEC, Inc. (NASDAQ: STEC) (“STEC”) for $31.00 per share. The investigation is to determine whether STEC violated the federal securities laws by making false and misleading statements in documents filed with the U.S. Securities and Exchange Commission in connection with its August 5, 2009 secondary offering.

What You May Do

If you purchased STEC shares on August 5, 2009 or as part of the August 5, 2009 Offering and/or have information that would assist GSK in its investigation or would like to discuss your legal rights, you may, without obligation or cost to you, e-mail or call Mark S. Goldman, Esq. at (888) 668-4130 or send an email to Mr. Goldman at goldman@gsk-law.com.

About Goldman Scarlato & Karon, P.C.

GSK prosecutes securities fraud, consumer fraud, price-fixing, ERISA class actions, and shareholder-derivative litigation throughout the United States. The Firm’s lawyers have recovered hundreds of millions of dollars on behalf of consumers, investors, and businesses.

To learn more about Goldman Scarlato & Karon, P.C., please visit our website, www.gsk-law.com.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,965.84 -104.56 -0.58%
S&P 500 2,094.45 -20.04 -0.95%
NASDAQ 4,945.1510 -71.7780 -1.43%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs